Nov 15, 2025
The Georgia Access to Medical Cannabis Commission approved a new dispensing license on Wednesday, bringing the statewide total to 19. This approval followed a significant patient enrollment threshold that triggered expansion under state law.
The commission’s executive director, Nick Paterson, explained that the program surpassed the 25,000 active patients mark some time ago, enabling the commission to approve the additional license. The commission unanimously voted to issue a dispensing license to FFD Georgia Holdings for a location in Atlanta. Notably, this was the only applicant.
The program is on track to approve additional licenses. Currently, the number of active patients stands at 33,314, approaching the 35,000 threshold. The law allows the commission to issue additional dispensing licenses after each 10,000 patient increase, starting from the 25,000 mark.
Despite some progress, the public comment period was dominated by urgent and frustrated statements from speakers who criticized the program’s framework. They argued that it restricts access and effectiveness. The primary concerns revolved around product limitations and strict qualifying conditions. Patients, advocates, and other members of the public called for legislative action to address these issues.
Georgia’s medical cannabis program, established a decade ago, has specific participation criteria. Patients with certain conditions, such as cancer or seizure disorders, are eligible. However, for several conditions, state law mandates a severe or end-stage diagnosis.
